Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have gone elsewhere without tax incentives approved by local officials last year.

Subscribe Now According to GSK, this new investment will be utilized to bring state-of-the-art drug substance manufacturing ...

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US. The programme represents the largest capital spend by ...

GSK's $800 million investment in its Marietta, Pennsylvania facility is its largest in U.S. manufacturing, boosting capacity for medicines and vaccines. Its drug Jemperli also received FDA ...